Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24372723)

1.

Synergistic effect of simvastatin plus NS398 on inhibition of proliferation and survival in hepatocellular carcinoma cell line.

Lee SJ, Hwang JW, Yim H, Yim HJ, Woo SU, Suh SJ, Hyun JJ, Jung SW, Koo JS, Kim JH, Seo YS, Yeon JE, Lee SW, Byun KS, Um SH.

J Gastroenterol Hepatol. 2014 Jun;29(6):1299-307. doi: 10.1111/jgh.12503.

PMID:
24372723
2.

Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.

Ralstin MC, Gage EA, Yip-Schneider MT, Klein PJ, Wiebke EA, Schmidt CM.

Mol Cancer Res. 2006 Jun;4(6):387-99.

3.
4.

NS398 induces apoptosis in non-small cell lung cancer cells.

Qiu R, Chen J, Sima J, Shen X, Liu D, Shen J.

J Cancer Res Clin Oncol. 2012 Jan;138(1):119-24. doi: 10.1007/s00432-011-1080-3. Epub 2011 Nov 3.

PMID:
22048655
5.

Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells.

Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q.

Cancer Invest. 2008 May;26(4):333-7. doi: 10.1080/07357900701788056.

PMID:
18443952
6.

Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.

Gao J, Niwa K, Takemura M, Sun W, Onogi K, Wu Y, Seishima M, Mori H, Tamaya T.

Int J Oncol. 2005 Mar;26(3):737-44.

PMID:
15703831
7.

Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis.

Che SM, Zhang XZ, Hou L, Song TB.

Cancer Invest. 2010 Aug;28(7):679-88. doi: 10.3109/07357907.2010.483504.

PMID:
20486853
8.

Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.

Zhang M, Zhang H, Cheng S, Zhang D, Xu Y, Bai X, Xia S, Zhang L, Ma J, Du M, Wang Y, Wang J, Chen M, Leng J.

Tumour Biol. 2014 Jul;35(7):7135-45. doi: 10.1007/s13277-014-1963-4. Epub 2014 Apr 24.

PMID:
24760275
9.

The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.

Lampiasi N, Azzolina A, Umezawa K, Montalto G, McCubrey JA, Cervello M.

Cancer Lett. 2012 Sep 1;322(1):35-44. doi: 10.1016/j.canlet.2012.02.008. Epub 2012 Feb 16.

PMID:
22343223
10.

[NS398 induced apoptosis in pancreatic carcinoma cell strain BxPC-3 through a COX-2-in dependent pathway].

Huang DS, Xu X, Zheng SS, Cheng JF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Oct;27(5):601-5. Chinese.

PMID:
16274041
11.

NS398 inhibits the growth of Hep3B human hepatocellular carcinoma cells via caspase-independent apoptosis.

Park MK, Hwang SY, Kim JO, Kwack MH, Kim JC, Kim MK, Sung YK.

Mol Cells. 2004 Feb 29;17(1):45-50.

12.

Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.

Tu YS, Kang XL, Zhou JG, Lv XF, Tang YB, Guan YY.

Eur J Pharmacol. 2011 Nov 30;670(2-3):356-64. doi: 10.1016/j.ejphar.2011.09.031. Epub 2011 Sep 19.

PMID:
21958871
13.
14.

Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.

Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D.

Mol Carcinog. 2009 Jan;48(1):56-65. doi: 10.1002/mc.20455.

PMID:
18506760
15.

The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.

Zhang H, Ye Y, Bai Z, Wang S.

Dig Dis Sci. 2008 Aug;53(8):2195-203. doi: 10.1007/s10620-007-0139-0. Epub 2008 Mar 5.

PMID:
18320325
16.

COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.

Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.

Int J Mol Med. 2006 Jul;18(1):41-7.

PMID:
16786154
17.

[Effects of gastrin receptor antagonist and cyclooxygenase-2 inhibitor on proliferation and apoptosis of gastric cancer cell].

Sun WH, Su H, Zhang LJ, Shao Y, Xu HC, Zhang T, Xue YP, Ding GX, Cheng YL.

Zhonghua Yi Xue Za Zhi. 2006 Jan 24;86(4):250-4. Chinese.

PMID:
16677505
18.

The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer.

Munkarah AR, Ali-Fehmi R, Jiang JZ, Elhammady E, Malone JM Jr, Saed GM.

Anticancer Drugs. 2007 Sep;18(8):889-96.

PMID:
17667594
19.

Aspirin overcomes Navitoclax-resistance in hepatocellular carcinoma cells through suppression of Mcl-1.

Li G, Zhang S, Fang H, Yan B, Zhao Y, Feng L, Ma X, Ye X.

Biochem Biophys Res Commun. 2013 May 17;434(4):809-14. doi: 10.1016/j.bbrc.2013.04.018. Epub 2013 Apr 20.

PMID:
23611778
20.

Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells.

Munkarah AR, Genhai Z, Morris R, Baker VV, Deppe G, Diamond MP, Saed GM.

Gynecol Oncol. 2003 Mar;88(3):429-33.

PMID:
12648598
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk